{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:23:57Z","timestamp":1794036237095,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jnma.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:42:15Z","timestamp":1791020535000},"page":"101102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the effect of fibroscan and anthropometric factors on incidence and progression of non-diabetic metabolic Dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2693-4980","authenticated-orcid":false,"given":"Pragya","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Kumar","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-3387","authenticated-orcid":false,"given":"Abhishek","family":"Singhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-463X","authenticated-orcid":false,"given":"Sukhes","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of NAFLD\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"67","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jnma.2026.09.007_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a State-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0003","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jnma.2026.09.007_bib0004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome: an update","volume":"14","author":"Rector","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.jnma.2026.09.007_bib0005","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/healthcare11192696","article-title":"Interactions between metabolic syndrome, MASLD, and arterial stiffening: a single-center cross-sectional study","volume":"11","author":"Solomon","year":"2023","journal-title":"Healthcare"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0006","first-page":"1063","article-title":"Fatty liver: a disease of the 21st century","volume":"54","author":"Kotronen","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jnma.2026.09.007_bib0007","doi-asserted-by":"crossref","DOI":"10.4291\/wjgp.v15.i2.92791","article-title":"Metabolic dysfunction-associated steatotic liver disease heterogeneity: need of subtyping","volume":"15","author":"Habib","year":"2024","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.jnma.2026.09.007_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"36","key":"10.1016\/j.jnma.2026.09.007_bib0009","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jnma.2026.09.007_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","article-title":"Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial (M-CHAT)","volume":"86","author":"Lear","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.jnma.2026.09.007_bib0011","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.32131","article-title":"Metabolic dysfunction- associated fatty liver disease improves detection of high liver stiffness: the Rotterdam Study","volume":"75","author":"van Kleef","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jnma.2026.09.007_bib0012","first-page":"204","article-title":"Waist circumference and waist-to-hip ratio as predictors of mortality in men and women","volume":"16","author":"Katzmarzyk","year":"2015","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3350\/cmh.2018.0034","article-title":"Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis","volume":"24","author":"Lee","year":"2018","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0014","first-page":"631","article-title":"Longitudinal assessment of visceral adiposity and risk of incident MASLD","volume":"70","author":"Sun","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12876-025-03780-8","article-title":"Relationship between anthropometric measures and the risk of incident metabolic dysfunction-associated steatotic liver disease: a longitudinal study","volume":"25","author":"Ichikawa","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MCG.0000000000002079","article-title":"Exploring biomarkers in nonalcoholic fatty liver disease among individuals with type 2 diabetes mellitus","volume":"59","author":"Ahmadizar","year":"2025","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jnma.2026.09.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101903","article-title":"Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group","author":"Diaz","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jnma.2026.09.007_bib0018","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: an obesity medicine association (OMA) and expert joint perspective 2025","volume":"14","author":"Panganiban","year":"2025","journal-title":"Obes Pillars"},{"issue":"11","key":"10.1016\/j.jnma.2026.09.007_bib0019","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/diagnostics10110940","article-title":"Diagnostic accuracy of FibroScan and factors affecting measurements","volume":"10","author":"Oeda","year":"2020","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-024-02100-5","article-title":"Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.jnma.2026.09.007_bib0021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000527595","article-title":"Obesity-induced hepatic steatosis is partly mediated by visceral fat accumulation in subjects with overweight\/Obesity: a cross-sectional study","volume":"16","author":"Liu","year":"2023","journal-title":"Obes Fact"},{"key":"10.1016\/j.jnma.2026.09.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116069","article-title":"Roles of immune dysregulation in MASLD","volume":"170","author":"Dong","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.jnma.2026.09.007_bib0023","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol-Cell Physiol"},{"key":"10.1016\/j.jnma.2026.09.007_bib0024","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fendo.2020.00267","article-title":"The immune landscape of visceral adipose tissue during obesity and aging","volume":"11","author":"Khan","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.jnma.2026.09.007_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cld.1183","article-title":"Nonalcoholic fatty liver disease: the role of visceral adipose tissue","volume":"19","author":"Hanlon","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"20","key":"10.1016\/j.jnma.2026.09.007_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction- associated steatotic liver disease: its pathophysiology, association with Atherosclerosis and cardiovascular Disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jnma.2026.09.007_bib0027","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","article-title":"Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study","volume":"24","author":"Song","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0028","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0029","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3803\/EnM.2020.772","article-title":"Genetic and environmental factors contributing to visceral adiposity in Asian populations","volume":"35","author":"Williams","year":"2020","journal-title":"Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0030","first-page":"637","article-title":"Exercise and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"70","author":"Keating","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jnma.2026.09.007_bib0031","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/biomedicines9121890","article-title":"The visceral adiposity index in non-alcoholic fatty liver disease and Liver Fibrosis-systematic review and Meta-analysis","volume":"9","author":"Ismaiel","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.jnma.2026.09.007_bib0032","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.numecd.2022.01.009","article-title":"Visceral adipose tissue quality was associated with nonalcoholic fatty liverdisease, independent of its quantity","volume":"32","author":"Igarashi","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jnma.2026.09.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/srep38214","article-title":"A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese","volume":"6","author":"Xia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnma.2026.09.007_bib0034","article-title":"Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease","volume":"2011","author":"Mirza","year":"2011","journal-title":"ISRN Gastroenterol"},{"key":"10.1016\/j.jnma.2026.09.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154455","article-title":"The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"115","author":"Koutoukidis","year":"2021","journal-title":"Metabolism"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:25:25Z","timestamp":1794032725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968426001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0027968426001720"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2026.09.007","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the effect of fibroscan and anthropometric factors on incidence and progression of non-diabetic metabolic Dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Medical Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101102"}}